Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
21 January, 2018 12:11 IST
Sun Pharma receives EIR from USFDA for Dadra facility
Source: IRIS | 12 Oct, 2017, 10.23AM
Comments  |  Post Comment

Sun Pharmaceutical Industries has received an Establishment Inspection Report (EIR) from the US Food Drug and Administration (USFDA) in respect of Dadra facility based upon the company’s responses to the observation letter.

EIR is issued to the entity when the USFDA concludes that an inspection is closed under Title 21 Section 20.64 (d) (3) of Code of Federal Regulation.

Total volume of shares traded on the bourses today was lower by 42.34% to 3,573,833 compared with 22-day average volume of 6,197,935.

Shares of the company gained Rs 9.55, or 1.82%, to trade at Rs 535.35. The total volume of shares traded was 193,487 at the BSE (10.07 a.m., Thursday).



Sun Pharmaceutical Industries Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Reliance Q3 profit up 25.5%; GRM at USD 11.6/bbl - 19-Jan-2018 18:34
HDFC Bank Q3 net grows 20% to Rs 41.51 bn - 19-Jan-2018 18:07
Wipro Q3 earnings fall 12% q-o-q to Rs 19.3 bn - 19-Jan-2018 17:56
Lupin launches generic Vibra-Tabs tablet in US - 19-Jan-2018 15:56
HCL Tech Q3 profit jumps 6% to Rs 21.94 bn - 19-Jan-2018 11:45
Suven Life Sciences secures 2 overseas product patents - 18-Jan-2018 15:26
Yes Bank Q3 profit rises 22% to Rs 10.76 bn - 18-Jan-2018 15:24
Sanghvi Forging & Engg bags new orders worth Rs 110 mn - 18-Jan-2018 10:17
Tata Consultancy Services expands partnership with Shure Inc - 18-Jan-2018 10:13
Ashok Leyland signs Lol with Phinergy, Israel for high energy EV - 17-Jan-2018 16:20
Transformers & Rectifiers India receives Rs 1.26 bn order - 17-Jan-2018 16:05
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer